Low density lipoprotein receptor-related protein (LRP) expression varies among Hep G2 cell lines

被引:8
作者
Grimsley, PG
Quinn, KA
Chesterman, CN
Owensby, DA [1 ]
机构
[1] Univ New S Wales, Ctr Thrombosis & Vasc Res, Sydney, NSW 2052, Australia
[2] Illawarra Reg Hosp, Dept Cardiol, Wollongong, NSW, Australia
基金
英国医学研究理事会;
关键词
expression; LRP; Hep G2 cells; plasminogen activators;
D O I
10.1016/S0049-3848(97)00287-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The multiligand receptor, low density lipoprotein receptor-related protein (LRP), is implicated in processes such as atherosclerosis and fibrinolysis through its mediation of the catabolism of lipoproteins, proteases, and protease inhibitor complexes. The hepatoma cell line Hep G2 expresses LRP and has been used widely to investigate the catabolism of LRP ligands including tissue-type plasminogen activator (tPA). However, the mechanism and degree by which tPA interacts with Hep G2 has been reported with some inconsistencies which may reflect variation in their level of LRP expression, To address this possibility we characterized, antigenically and functionally, LRP expression in high and low passage Hep G2 cells both from the parental line (ATCC sourced) and a cloned subline, a16. The LRP contribution to I-125-tpA binding varied from 65% for high passage a16 cells, to 20% for low passage parent cells as quantified by inhibition in the presence of 39-kD receptor associated protein (RAP) which prevents binding of all known LRP ligands, The same trend in LRP expression among Hep G2 sublines was further evident in their ability to degrade I-125-tpA and survive Pseudomonas exotoxin A challenge. These results imply wide variability in basal LRP expression among Hep G2 lines dependent on cell lineage and long-term culture conditions. (C) 1998 Elsevier Science Ltd.
引用
收藏
页码:485 / 498
页数:14
相关论文
共 47 条
[1]   RECEPTOR-MEDIATED ENDOCYTOSIS OF PLASMINOGEN ACTIVATORS AND ACTIVATOR/INHIBITOR COMPLEXES [J].
ANDREASEN, PA ;
SOTTRUPJENSEN, L ;
KJOLLER, L ;
NYKJAER, A ;
MOESTRUP, SK ;
PETERSEN, CM ;
GLIEMANN, J .
FEBS LETTERS, 1994, 338 (03) :239-245
[2]  
BATTEY FD, 1994, J BIOL CHEM, V269, P23268
[3]  
BIRD SD, 1994, IN VITRO CELL DEV-AN, V30A, P420
[4]  
BU GJ, 1994, BLOOD, V83, P3427
[5]   LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN ALPHA-2-MACROGLOBULIN RECEPTOR IS AN HEPATIC RECEPTOR FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
BU, GJ ;
WILLIAMS, S ;
STRICKLAND, DK ;
SCHWARTZ, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7427-7431
[6]  
BU GJ, 1993, J BIOL CHEM, V268, P13002
[7]   PSEUDOMONAS EXOTOXIN-MEDIATED SELECTION YIELDS CELLS WITH ALTERED EXPRESSION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN [J].
FITZGERALD, DJ ;
FRYLING, CM ;
ZDANOVSKY, A ;
SAELINGER, CB ;
KOUNNAS, M ;
WINKLES, JA ;
STRICKLAND, D ;
LEPPLA, S .
JOURNAL OF CELL BIOLOGY, 1995, 129 (06) :1533-1541
[8]   UROKINASE BINDING AND CATABOLISM BY HEP G2 CELLS IS PLASMINOGEN-ACTIVATOR INHIBITOR-1 DEPENDENT, ANALOGOUS TO INTERACTIONS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR WITH THESE CELLS [J].
GRIMSLEY, PG ;
NORMYLE, JF ;
BRANDT, RA ;
JOULIANOS, G ;
CHESTERMAN, CN ;
HOGG, PJ ;
OWENSBY, DA .
THROMBOSIS RESEARCH, 1995, 79 (04) :353-361
[9]   ALPHA-FUCOSE-MEDIATED BINDING AND DEGRADATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY HEPG2 CELLS [J].
HAJJAR, KA ;
REYNOLDS, CM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) :703-710
[10]   VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR BINDS AND MEDIATES ENDOCYTOSIS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR-TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR COMPLEX [J].
HEEGAARD, CW ;
SIMONSEN, ACW ;
OKA, K ;
KJOLLER, L ;
CHRISTENSEN, A ;
MADSEN, B ;
ELLGAARD, L ;
CHAN, L ;
ANDREASEN, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (35) :20855-20861